P95

Contagious Thinking with Thomas Verstraeten

Health EN ↓ 3 episodes

Contagious Thinking is the official podcast of P95, hosted by CEO Thomas Verstraeten. Each episode explores the critical intersections of data, disease, and decision-making — spotlighting voices shaping the future of epidemiology, real-world evidence, infectious disease research, and public health strategy. These short-form video podcast episodes are designed to spark meaningful conversation, deepen insight, and move global health forward. This isn’t a dry data download, it’s thoughtful dialogue with the people driving real change.

Author

P95

Episodes

Latin America’s Rising Role in Global Clinical Research: Opportunities Ahead 30.09.2025 26:07

In this episode of Contagious Thinking, host Thomas Verstraeten, CEO at P95, speaks with Rodrigo DeAntonio, Population Intelligence Director and Researcher at Cevaxin by endpoints clinical Research Network. Together, they explore how Latin America has become a key player in global clinical research — from early vaccine trials for rotavirus, HPV, and pneumococcal disease to its pivotal role during...

Africa’s Role in Global Vaccine Development: More Than a Trial Site 30.07.2025 28:09

In this episode, Thomas Verstraeten, CEO of P95, speaks with Edward Sobe-Yarig, P95’s Operations Lead in West Africa, about Africa’s growing leadership in clinical research. Sobe shares how the continent has moved beyond infrastructure challenges to build advanced capabilities. From local expertise to evolving regulations and strong regional networks, Africa is now a driving force in global vaccin...

14 Years On: Origins, Impact, and the Future of Evidence 16.06.2025 29:44

To launch the podcast and mark 14 years of P95, Thomas Verstraeten, CEO of P95, sits down with the company’s first employee, Margarita Riera, now Epidemiology Strategy Director. Together, they reflect on how infectious disease remains a core public health challenge, how P95’s approach has shifted in response to sponsor needs and global-local tensions, and why epidemiology is central to making tria...